drugset / Trial / NCT00839072

Comparative Bioavailability Study of Extended-release and Immediate-release Trazodone in Healthy Adult Volunteers

NCT00839072

Phase 1 Completed 24 enrolled Labopharm Inc. Algorithme Pharma Inc · collab
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of the study is to compare the pharmacokinetic profiles of extended-release and immediate-release trazodone formulations

Timeline

Start
2009-02
Primary completion
2009-02
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Trazodone Small molecule 100 mg
Subject Trazodone Small molecule 300 mg

Indications

No indication recorded.